Deniz Kent, PhD is the Co-Founder and Chief Executive Officer of Prolific Machines, a biotechnology company ushering in a new era of biotechnology using light. Founded in 2020, the Bay Area company is redefining biologics manufacturing with its pioneering Photomolecular platform, leveraging proprietary optogenetic tools and closed-loop control software to solve major protein production challenges across difficult-to-produce protein and antibody therapeutics. Deniz cultivated expertise in biological systems through academic research and professional innovation. He earned his PhD in the Centre for Stem Cells and Regenerative Medicine at King's College London. Prior to his PhD, Deniz had worked in a cancer immunotherapy lab at the University of Bristol and worked on a single-dose cure for Asthma at GlaxoSmithKline. He also received his master’s degree in biomedical and translational science from King’s College London and his bachelor’s degree from the University of Bristol.

‍